Compound class:
Synthetic organic
Comment: This is a macrocyclic peptide that targets the STUB1 E3 ubiquitin ligase [1]. 22d was developed from a short linear peptide (LWWPD) that binds STUB1 [2], to guide the design of more selective pharmacological inhibitors as tool compounds for target validation. Although 22d retains the binding affinity for STUB1 of the linear peptide, suboptimal cellular permeability means that this construct is not suitable for experiments in cells or in vivo.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Ng S, Brueckner AC, Bahmanjah S, Deng Q, Johnston JM, Ge L, Duggal R, Habulihaz B, Barlock B, Ha S et al.. (2022)
Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1. J Med Chem, [Epub ahead of print]. [PMID:35853179] |
2. Ravalin M, Theofilas P, Basu K, Opoku-Nsiah KA, Assimon VA, Medina-Cleghorn D, Chen YF, Bohn MF, Arkin M, Grinberg LT et al.. (2019)
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases. Nat Chem Biol, 15 (8): 786-794. [PMID:31320752] |